The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
By S. Lauer, K. Grantz, Qifang Bi, Forrest K. Jones, Q. Zheng, Hannah R. Meredith, A. Azman, N. Reich, Justin Lessler. Annals of Internal Medicine, 2020
5,470 citations recorded by the source corpus.
Background: A novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in China in December 2019. There is limited support for many of its key epidemiologic features, including the incubation period for clinical disease (coronavirus disease 2019 [COVID-19]), which has important implications for surveillance and control activities. Objective: To estimate the length of the incubation period of COVID-19 and describe its public health implications. Design: Pooled analysis of confirmed COVID-19 cases reported between 4 January 2020 and 24 February 2020. Setting: News reports and press releases from 50 provinces, regions, and countries outside Wuhan, Hubei province, China. Participants: Persons with confirmed SARS-CoV-2 infection outside Hubei province, China. Measurements: Patient demographic characteristics and dates and times of possible exposure, symptom onset, fever onset, and hospitalization. Results: There were 181 confirmed cases with identifiable exposure and symptom onset windows to estimate the incubation period of COVID-19. The median incubation period was estimated to be 5.1 days (95% CI, 4.5 to 5.8 days), and 97.5% of those who develop symptoms will do so within 11.5 days (CI, 8.2 to 15.6 days) of infection. These estimates imply that, under conservative assumptions, 101 out of every 10 000 cases (99th percentile, 482) will develop symptoms after 14 days of active monitoring or quarantine. Limitation: Publicly reported cases may overrepresent severe cases, the incubation period for which may differ from that of mild cases. Conclusion: This work provides additional evidence for a median incubation period for COVID-19 of approximately 5 days, similar to SARS. Our results support current proposals for the length of quarantine or active monitoring of persons potentially exposed to SARS-CoV-2, although longer monitoring periods might be justified in extreme cases. Primary Funding Source: U.S. Centers for Disease Control and Prevention, National Institute of Allergy and Infectious Diseases, National Institute of General Medical Sciences, and Alexander von Humboldt Foundation.
Subfields: Infectious Diseases, Modeling and Simulation
View Paper: https://www.semanticscholar.org/paper/00d4f4b2e38a2fbe15c672c21c522e2f95264cb0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
Citations in the corpus
- COVID-19 and diabetes: Knowledge in progress (2020, neutral): “[8] Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al.”
- The geography of COVID‐19 and the structure of local economies: The case of Italy (2020, background): “This could generate a core‐periphery pattern in the spatiality of COVID‐19, which might follow the lines of the local economic landscape and the tradability of its outputs.”
- COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options (2020, background): “6 days] and include fever, dry cough, fatigue, ageusia, anosmia, and headache.(24) Other non-specific symptoms have also been reported, which included nasal congestion, rhinorrhea, sore throat, myalgia, poor appetite, and diarrhoea.”
- A combined deep CNN-LSTM network for the detection of novel coronavirus (COVID-19) using X-ray images (2020, neutral): “The RT-PCR test kits are in huge shortage, in addition to inefficiency [6].”
- COVID‐19 and Older Adults: What We Know (2020, background): “1 days.(7,8) A recent study found that SARSCoV-2 lasts in aerosols for up to 3 hours and remains detectable for up to 72 hours on plastic and stainless-steel surfaces, 24 hours on cardboard, and 4 hours on copper.”
- An Economic Model of the Covid-19 Epidemic: The Importance of Testing and Age-Specific Policies (2020, result): “These numbers are close to those reported by Lauer et al. (2020) and Backer, Klinkenberg, and Wallinga (2020) and the WHO.11 The parameter φ(0, a) will then control the fraction of agents that recover from mild symptoms or need to move to an ICU.”
- To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic (2020, neutral): “…workers (MacIntyre et al., 2017; Offeddu et al., 2017), experimental studies as reviewed in (Davies et al., 2013; Dharmadhikari et al., 2012; Lai et al., 2012; Patel et al., 2016; van der Sande et al., 2008), and case control data from the 2003 SARS epidemic (Lau et al., 2004; Wu et al., 2004).”